ClinicalTrials.gg
RecruitingNCT07283458TICOALA-SOINSUpdated Jul 21, 2026

Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS)

An interventional study of TICOALA in Typical Development, Typically Developing Children Ages 3 to 6 and Typical Preschoolers Who Can Not Zipper, sponsored by Centre Hospitalier St Anne. Recruiting at 1 site in France. Open to participants aged 3 Years to 7 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by Centre Hospitalier St Anne · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
3 Years to 7 Years
Sex
All
01

Study summary

Language is central to children's cognitive, emotional, and social development, and language difficulties are a frequent reason for consultation in child psychiatry, often co-occurring with psychiatric disorders. Yet, systematic language assessment is rarely possible due to the limited availability of speech-language therapists in these services.

The TICOALA tool (Interactive Test of Language Comprehension and Learning on tablet) offers a quick and engaging way to evaluate lexical and syntactic comprehension and word learning. This study aims to assess its acceptability among children aged 3-7 attending a child psychiatry service in Paris, as well as among clinicians and parents. Secondary goals include testing the feasibility of a larger study, describing children's language skills, and examining how these relate to clinical and background variables.

Read the detailed description

Language is intrinsically linked to children's cognitive, social, emotional, and psychological development, and plays a crucial role in both academic achievement and psychosocial adjustment. In child psychiatry, language difficulties are a common reason for consultation and are frequently associated with psychiatric conditions such as anxiety disorders or attention difficulties. However, due to the limited availability of speech-language therapists in these settings, systematic language assessments are rarely conducted.

The TICOALA tool (Interactive Test of Language Comprehension and Learning on tablet) offers a quick and engaging way to evaluate children's lexical and syntactic comprehension, as well as their ability to learn new words. Integrating this tool into clinical practice could provide an initial language assessment and help guide referrals for formal speech-language evaluation.

Main Objective To assess the acceptability of the TICOALA tool among children attending our child psychiatry service.

Secondary Objectives

  • To evaluate its acceptability for clinicians (psychiatrists, psychologists) and parents.
  • To assess the acceptability of the parental clinical questionnaire.
  • To determine the feasibility of conducting a larger-scale study.
  • To describe the language skills (lexical, syntactic, word learning) of children in our service.
  • To analyze the relationship between language skills and clinical/anamnestic data (socio-economic background, play and screen exposure, language experience, etc.).

Target Population Children aged 3-7 years consulting at the child psychiatry service in the 14th arrondissement of Paris.

02

Conditions studied

  • Typical Development
  • Typically Developing Children Ages 3 to 6
  • Typical Preschoolers Who Can Not Zipper
  • Children
  • Children Behavior Problem
  • FRENCH STUDY

Browse trials for

Keywords

  • language assessment
03

In context

Problem Behavior

178 studies on the registry are indexed under Problem Behavior; 47 are open to participants now.

This study's planned enrollment of 50 is below the median of 90 across 165 interventional studies indexed under Problem Behavior.

Browse Problem Behavior studies →

Lead sponsor

Centre Hospitalier St Anne is the lead sponsor of 101 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children (boys or girls) aged 3-7 years
  • Consulting in the child psychiatry service
  • Enrolled in a French-speaking school

Exclusion criteria

Exclusion Criteria:

  • Inability to use the tablet-based TICOALA tool due to severe sensory (blindness, deafness), motor, or intellectual impairment
  • Refusal of the child or parents/legal guardians to participate
  • Child not affiliated with the French social security system
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Other
    Children with language comprehension and learning difficulties

    Other: TICOALA

Interventions

  • OtherTICOALA

    The TICOALA tool (Interactive Test of Language Comprehension and Learning on tablet) offers a quick and engaging way to evaluate children's lexical and syntactic comprehension, as well as their ability to learn new words. Integrating this tool into clinical practice could provide an initial language assessment and help guide referrals for formal speech-language evaluation.

06

What researchers measure

Primary outcomes

  1. Acceptability of the TICOALA tool among children attending our child psychiatry service

    This objective will be evaluated using a questionnaire with a 5-point Likert scale, with a composite evaluation criterion based on three elements: the child's opinion, their level of attention, and their level of motivation. The questionnaire will be completed by the consultant, reporting the child's opinion and their clinical observations (attention, motivation) during the assessment.

    Time frame: 4 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Only anonimyzed results will be shared. Each child will be assigned a code. Data shared will simply include scores on the tasks and answers in the questionnaires without any information linked to each individual identity.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07283458
Collaborators
Université Paris Cité, Centre National de la Recherche Scientifique, France
Responsible party
Sponsor
First posted
Dec 15, 2025
Start date
Mar 19, 2026
Primary completion
Mar 19, 2028 (estimated)
Completion
Mar 19, 2028 (estimated)
Last update
Jul 21, 2026

Study contacts

Khaoussou SYLLA, Dr
Contact
K.SYLLA@ghu-paris.fr
+33145658486
Viviane AWASSI
Contact
v.awassi@ghu-paris.fr
+ 33 1 45 65 84 86

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion